ADVERTISEMENT
Oncology Advances
Practical Management of Patients With Relapsed/Refractory MM Receiving Talquetamab
11/22/2023
Donna Catamero, ANP-BC, OCN, CCRC, Associate Director, Myeloma Translational Research, Mount Sinai Health System, New York, New York, provides guidance for administering talquetamab and discusses strategies for monitoring and managing adverse events (AEs) based on a study utilizing experience from the MonumenTAL-1 trial.
The Advanced Practice Provider (APP) Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!
